产品描述: | Uplarafenib (B-Raf IN 10) 是一种 BRAF 抑制剂,IC50 在 50-100 nM。Uplarafenib 具有抗肿瘤活性。 |
靶点: |
BRAF-V600E:< 50 nM (IC50);Braf:50-100 nM (IC50);Raf |
体外研究: |
Uplarafenib (Compound C09) (1 μM) shows more than 89% inhibition against BRAF and BRAF V600E. Uplarafenib shows an IC50 between 50 and 100 nM against BRAF, less than 50 nM against BRAF V600E. Uplarafenib (72 h) inhibits A375 and SK-MEL-28 cells growth but not CHL-1 and SK-MEL-31 cells. |
参考文献: |
1. Yong-Liang Zhu, et al. Certain Chemical Entities, Compositions, and Methods. Patent US20130053384 A1. |
溶解性: |
soluble in DMSO |
保存条件: |
-20℃ |
配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
1 mM |
2.022 ml |
10.111 ml |
20.223 ml |
5 mM |
0.404 ml |
2.022 ml |
4.045 ml |
10 mM |
0.202 ml |
1.011 ml |
2.022 ml |
50 mM |
0.04 ml |
0.202 ml |
0.404 ml |
|
注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |